Monday, June 15, 2026

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

U.S. FDA to Streamline IND Process: What It Means for Asian Biotech Competitiveness in 2027

The U.S. aims to streamline drug approval processes to compete with China and Australia in attracting clinical trials, enhancing biotech growth.

Tag: landmine explosion

No posts to display

Top News

- Our Sponsors Ad -

Follow us